<
Gerbisa-L
Sodium Picosulfate
Oral Solution BP
120ml Bottle Price : Rs. 145
Composition
Each 5 ml contains
Sodium Picosulfate BP 5 mg
Description
120ml Bottle Price : Rs. 145
Composition
Each 5 ml contains
Sodium Picosulfate BP 5 mg
Description
Gerbisa-L contains sodium Picosulfate a locally action laxative The chemical name of sodium Picosulfate is Disodium 4,4'-(2-pyridylmethylene) di (phenyl sulphate).
Sodium Picosulfate is locally acting laxative from the triaryimethane group which after bacterial cleavage in the colon, has a dual action with stimulation of the mucosa of both the large intestine and of the rectum. Stimulation of the mucosa of the large intestine results in colonic peristalsis with promotion of accumulation of water and consequently electrolytes in the colonic lumen. This results in simulation of defaecation, reduction of transit time and softening of the stool. Simulation of the rectum causes increased motility and a feeling of rectal fullness. The rectal effect may help to restore the 'call to stool' although its clinical relevance remains to be established.
After oral ingestion sodium Picosulfate reaches the colon without any appreciable absorption. Therefore, enterohepatic circulation is avoided. The active laxative compound, bis(p-hydroxypheny)-pyridyl-2-methane (BHPM) is formed by bacterial cleavage in the intestine. Consequently the onset of action of the preparation is usually between 6-12 hours, which is determined by the release of the active substance. After oral administration, only small amounts of the drug are systemically available. There is no relationship between the laxative effect and plasma levels of the active moiety.
Gerbisa-L is indicated for relief of constipation and bowel clearance before labour, surgery or radiological examination.
Gerbisa-L is contraindicated in patients with ileus, intestinal obstruction, acute abdominal conditions including appendicitis, acute inflammatory bowel diseases and severe abdominal pain associated with nausea and vomiting which may be indicative of the aforementioned severe conditions.
Gerbisa-L is also contraindicated in severe dehydration and in patients with known hypersensitivity to sodium Picosulfate or any other components of the product.
As with all laxatives, Gerbisa-l should not be taken on a continuous daily basic for more than five days without investigating the cause of constipation. Prolonged excessive use may lead to fluid and electrolyte imbalance and hypokalaemia.
Dizziness and/or syncrope have been reported in patients who have taken sodium Picosulfate. The details available for these cases suggest that the events would be consistent with defaecation syncope(or syncope attributable to straining at stool) or with a vasovagal response to abdominal pain related to the constipation and not necessary to the administration of sodium Picosulfate itself.
Gerbisa-l should not be taken by children under 10 years without medical advice.
There are no adequate and well-controlled studied in pregnant woman. Long Experience has show no evidence of undesirable or damaging effects during pregnancy. Clinical data show that neither the active moiety of sodium Picosulfate (BHPM or bis-(p-hydroxypheny)-pyridy-2-methane) not its glucuronides are excreted into the milk of healthy lactating females. Nevertheless, as with all medicines. Gerbisa-l should not be taken pregnancy. Especially the first trimester and during breast feeding unless the expected benefit is thought to outweigh any possible risk and only on medical advice. No studies on the effect on human fertility have been conducted. Nonclinical studies did not reveal any effect on fertility.
The concomitant use of diuretic or adreno corticosteroids may increase the risk of electrolyte imbalance if excessive doses of sodium Picosulfate are taken. Electrolyte imbalance may lead to increased sensitivity to cardiac glycosides. Concurrent administration of antibiotics may reduce the laxative action of this product.
Adverse events reported with use of sodium Picosulfate are: Gastrointestinal discovered: Diarrhea, abdominal discomfort, abdominal pain, abdominal cramps, nausea, vomiting.
Nervous system disorders : Dizziness, syncope (dizziness and syncope occurring after talking sodium Picosulfate appear to be consistent with a vasovagal response e.g. to abdominal spasm, defaecation)
Immune system disorders : Hypersensitivity including angioneurotic oedema and skin reactions.
Symptoms : if high doses are taken diarrhoea, abdominal cramps and a clinically significant loss of fluid, potassium and other electrolytes can occur. Furthermore, cases of colonic mucosal ischemia have been reported in association with doses of sodium Picosulfate considerably higher than those recommended for the routine management of constipation. Laxative when taken in chronic overdosage may cause chronic diarrhoea, abdominal pain, hypokalaemia, secondary hyperaldosteronism and rental calculi. Rental tubular damage, metabolic alkaloais and muscle weakness secondary to hypokalaemia have also been described in association with chronic laxative abuse.
Clinical Pharmacology
Sodium Picosulfate is locally acting laxative from the triaryimethane group which after bacterial cleavage in the colon, has a dual action with stimulation of the mucosa of both the large intestine and of the rectum. Stimulation of the mucosa of the large intestine results in colonic peristalsis with promotion of accumulation of water and consequently electrolytes in the colonic lumen. This results in simulation of defaecation, reduction of transit time and softening of the stool. Simulation of the rectum causes increased motility and a feeling of rectal fullness. The rectal effect may help to restore the 'call to stool' although its clinical relevance remains to be established.
Pharmacokinetics
After oral ingestion sodium Picosulfate reaches the colon without any appreciable absorption. Therefore, enterohepatic circulation is avoided. The active laxative compound, bis(p-hydroxypheny)-pyridyl-2-methane (BHPM) is formed by bacterial cleavage in the intestine. Consequently the onset of action of the preparation is usually between 6-12 hours, which is determined by the release of the active substance. After oral administration, only small amounts of the drug are systemically available. There is no relationship between the laxative effect and plasma levels of the active moiety.
Indications
Gerbisa-L is indicated for relief of constipation and bowel clearance before labour, surgery or radiological examination.
Contraindications
Gerbisa-L is contraindicated in patients with ileus, intestinal obstruction, acute abdominal conditions including appendicitis, acute inflammatory bowel diseases and severe abdominal pain associated with nausea and vomiting which may be indicative of the aforementioned severe conditions.
Gerbisa-L is also contraindicated in severe dehydration and in patients with known hypersensitivity to sodium Picosulfate or any other components of the product.
Precautions and Warnings
Dizziness and/or syncrope have been reported in patients who have taken sodium Picosulfate. The details available for these cases suggest that the events would be consistent with defaecation syncope(or syncope attributable to straining at stool) or with a vasovagal response to abdominal pain related to the constipation and not necessary to the administration of sodium Picosulfate itself.
Gerbisa-l should not be taken by children under 10 years without medical advice.
Usage in Pregnancy and Lactation
There are no adequate and well-controlled studied in pregnant woman. Long Experience has show no evidence of undesirable or damaging effects during pregnancy. Clinical data show that neither the active moiety of sodium Picosulfate (BHPM or bis-(p-hydroxypheny)-pyridy-2-methane) not its glucuronides are excreted into the milk of healthy lactating females. Nevertheless, as with all medicines. Gerbisa-l should not be taken pregnancy. Especially the first trimester and during breast feeding unless the expected benefit is thought to outweigh any possible risk and only on medical advice. No studies on the effect on human fertility have been conducted. Nonclinical studies did not reveal any effect on fertility.
Drug Interactions
Adverse Effects
Adverse events reported with use of sodium Picosulfate are: Gastrointestinal discovered: Diarrhea, abdominal discomfort, abdominal pain, abdominal cramps, nausea, vomiting.
Nervous system disorders : Dizziness, syncope (dizziness and syncope occurring after talking sodium Picosulfate appear to be consistent with a vasovagal response e.g. to abdominal spasm, defaecation)
Immune system disorders : Hypersensitivity including angioneurotic oedema and skin reactions.
Overdosage
Symptoms : if high doses are taken diarrhoea, abdominal cramps and a clinically significant loss of fluid, potassium and other electrolytes can occur. Furthermore, cases of colonic mucosal ischemia have been reported in association with doses of sodium Picosulfate considerably higher than those recommended for the routine management of constipation. Laxative when taken in chronic overdosage may cause chronic diarrhoea, abdominal pain, hypokalaemia, secondary hyperaldosteronism and rental calculi. Rental tubular damage, metabolic alkaloais and muscle weakness secondary to hypokalaemia have also been described in association with chronic laxative abuse.
Therapy
Within a short time of ingestion, absorption can be minimised or prevented by including vomiting or by gastric lavage. Replacement of fluids and correction of electrolyte imbalance may be required. This is especially important in the elderly and the young. Administration of antispasmodics may be of some value.
Adult and children over 10 years :
one to two 5ml spoonfuls (5-10mg) at night.
Children (4-10 years) :
Half to one 5 ml spoonful (2.5-5mg) at night.
Children under 4 years :
The recommended dosage is 250 micrograms per kilogram body weight.
For oral administration only. Not to be taken by children under 10 years without medical advice. In the management of constipation, once regularly has restarted dosage should be reduced and can usually be stopped. Can be diluted with purified water.
Dose and Method of Administration
Unless otherwise prescribed by the doctor, the following dosages are recommended
Adult and children over 10 years :
one to two 5ml spoonfuls (5-10mg) at night.
Children (4-10 years) :
Half to one 5 ml spoonful (2.5-5mg) at night.
Children under 4 years :
The recommended dosage is 250 micrograms per kilogram body weight.
For oral administration only. Not to be taken by children under 10 years without medical advice. In the management of constipation, once regularly has restarted dosage should be reduced and can usually be stopped. Can be diluted with purified water.
Related Posts
The way of describing about Technology is fine.Im really happy to read this.please share more like this.
ReplyDeleteclinical sas training in chennai
clinical sas training
clinical sas Training in Anna Nagar
clinical sas Training in T Nagar
SAS Training in Chennai
SAS Course in Chennai
SAS Training Institute in Chennai
QTP Training in Chennai
The information is good. I preview this type of good blog only. Good job.
ReplyDeleteHtml5 Training in Chennai
Html5 Training Course
Html5 Training in Velachery
DOT NET Training in Chennai
.Net course in chennai
C C++ Training in Chennai
LoadRunner Training in Chennai
Html5 Training in Chennai
Hi,
ReplyDeleteI read your all post, These are very useful for enhancing my knowledge and I got many unique details from your wonderful post. Good job keep it up...!
Primavera Course in Chennai
Best Primavera Training in Chennai
Tableau Training in Chennai
Spark Training in Chennai
Unix Training in Chennai
Power BI Training in Chennai
Excel Training in Chennai
Linux Training in Chennai
Oracle Training in Chennai
Social Media Marketing Courses in Chennai
financial advisor in bangalore
ReplyDeleteEducation franchise is a major part of the franchise business and also a great opportunity to start your own business. There are all kinds of Education & training ...
ReplyDeleteGreat experience for me by reading this blog. Thank you for the wonderful article.
java interview questions and answers for freshers
j2ee interview questions
selenium automation framework interview questions and answers
digital marketing interview questions and answers pdf
hadoop testing interview questions and answers for experienced
oracle pl sql interview questions
data scientist interview
questions and answers
no deposit bonus forex 2021 - takipçi satın al - takipçi satın al - takipçi satın al - takipcialdim.com/tiktok-takipci-satin-al/ - instagram beğeni satın al - instagram beğeni satın al - google haritalara yer ekleme - btcturk - tiktok izlenme satın al - sms onay - youtube izlenme satın al - google haritalara yer ekleme - no deposit bonus forex 2021 - tiktok jeton hilesi - tiktok beğeni satın al - binance - takipçi satın al - uc satın al - finanspedia.com - sms onay - sms onay - tiktok takipçi satın al - tiktok beğeni satın al - twitter takipçi satın al - trend topic satın al - youtube abone satın al - instagram beğeni satın al - tiktok beğeni satın al - twitter takipçi satın al - trend topic satın al - youtube abone satın al - instagram beğeni satın al - tiktok takipçi satın al - tiktok beğeni satın al - twitter takipçi satın al - trend topic satın al - youtube abone satın al - instagram beğeni satın al - perde modelleri - instagram takipçi satın al - instagram takipçi satın al - cami avizesi - marsbahis
ReplyDeleteTül perde modelleri
ReplyDeletesms onay
mobil ödeme bozdurma
Nft Nasıl Alınır
ANKARA EVDEN EVE NAKLİYAT
TRAFİK SİGORTASI
DEDEKTOR
kurma websitesi
Ask Romanlari
EASEUS Data Recovery Wizard Free Edition is free data recovery software to easily and quickly recover deleted, formatted, or lost data from your Easeus Data Recovery Crack
ReplyDeleteFlvto Youtube Downloader Crack is the downloaded programming through which clients can undoubtedly download any video from YouTube. Flvto Lizenzschlüssel
ReplyDeleteKeep It Up.CCleaner Free Download with Crack
ReplyDeleteGreat Work.EaseUS Data Recovery Crack
ReplyDelete